CK0804 is a first in class, CXCR4hi Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...

After finishing the season 3-9, several Colorado Buffaloes have announced their intentions to enter the NCAA Transfer Portal. To make the situation tougher for Colorado, seven of the Buffaloes' 15 ...

We’re roughly halfway through the MLB offseason, and about half of the top available free agents are still looking for their next home. The reliever market heated up first this winter, with Edwin Diaz ...